- A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
-
Park YC, Ouh YT, Sung MH, Park HG, Kim TJ, Cho CH, Park JS, Lee JK
- KMID: 2458895
- J Gynecol Oncol.
- 2019 Nov;30(6):e88.
- doi: 10.3802/jgo.2019.30.e88
OBJECTIVE: Persistent infection of HPV increases the chance of carcinoma in situ of cervix through stages of cervical intraepithelial neoplasia (CIN) 1, 2, and 3, and finally progresses into cervical... -
- CITED
-
- Close
- SHARE
-
- Close
